Initiator Pharma A/S - ESG Rating & Company Profile powered by AI
This analysis of Initiator Pharma A/S is prepared by All Street Sevva using advanced artificial intelligence. Browse to the bottom of this webpage for potential risks for Initiator Pharma A/S based on sector, location and size. This ESG rating for Initiator Pharma A/S represents the company's reporting of the UN SDGs.
Initiator Pharma A/S in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Initiator Pharma A/S | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Initiator Pharma A/S have an accelerator or VC vehicle to help deliver innovation?
Does Initiator Pharma A/S disclose current and historical energy intensity?
Does Initiator Pharma A/S report the average age of the workforce?
Does Initiator Pharma A/S reference operational or capital allocation in relation to climate change?
Does Initiator Pharma A/S disclose its ethnicity pay gap?
Does Initiator Pharma A/S disclose cybersecurity risks?
Does Initiator Pharma A/S use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Initiator Pharma A/S offer flexible work?
Does Initiator Pharma A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Initiator Pharma A/S disclose the number of employees in R&D functions?
Does Initiator Pharma A/S plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Initiator Pharma A/S conduct supply chain audits?
Does Initiator Pharma A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Initiator Pharma A/S conduct 360 degree staff reviews?
Does Initiator Pharma A/S disclose the individual responsible for D&I?
Does Initiator Pharma A/S disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Initiator Pharma A/S disclose current and / or historical scope 2 emissions?
Does Initiator Pharma A/S disclose water use targets?
Does Initiator Pharma A/S have careers partnerships with academic institutions?
Did Initiator Pharma A/S have a product recall in the last two years?
Does Initiator Pharma A/S disclose incidents of discrimination?
Does Initiator Pharma A/S allow for Work Councils/Collective Agreements to be formed?
Has Initiator Pharma A/S issued a profit warning in the past 24 months?
Does Initiator Pharma A/S disclose parental leave metrics?
Does Initiator Pharma A/S disclose climate scenario or pathway analysis?
Does Initiator Pharma A/S disclose current and / or historical scope 1 emissions?
Does Initiator Pharma A/S explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Initiator Pharma A/S disclose the pay ratio of women to men?
Does Initiator Pharma A/S support suppliers with sustainability related research and development?
Does Initiator Pharma A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Initiator Pharma A/S reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Initiator Pharma A/S involved in embryonic stem cell research?
Does Initiator Pharma A/S disclose GHG and Air Emissions intensity?
Does Initiator Pharma A/S disclose its waste policy?
Does Initiator Pharma A/S report according to TCFD requirements?
Does Initiator Pharma A/S plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Initiator Pharma A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Initiator Pharma A/S disclose energy use targets?
Does Initiator Pharma A/S disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Initiator Pharma A/S have a policy relating to cyber security?
Have a different question?
Potential Risks for Initiator Pharma A/S
These potential risks are based on the size, segment and geographies of the company.
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.